GENE ONLINE|News &
Opinion
Blog

Celltrion
Celltrion and WuXi XDC Partner to Advance ADC Development and Manufacturing
2024-01-26
GeneOnline’s Weekly News Highlights: Oct 22-Oct 27
2023-10-31
The First and Only FDA-approved Drug for Chronic Digestive Diseases by Celltrion USA
2023-10-25
GeneOnline’s Weekly News Highlights: Sept 4-Sept 8
2023-09-12
Bora and Celltrion Join Forces To Distribute Oral Drugs Across APAC
2023-04-07
Celltrion’s Avastin Biosimilar Gets FDA Greenlight
2022-09-29
Celltrion’s New Antibody Is Effective against the Omicron Variant
2022-01-06
Korea’s Celltrion Pushes for Broader Use of COVID-19 Treatment both Domestically And Abroad
2021-08-12
Celltrion Bags FDA’s Emergency Approval for COVID-19 Rapid Test, Prepares to Ship Supply to the US
2021-04-21
Two South Korean Companies Look to Capture the Biosimilars Market Worth Billions
2020-12-01
Celltrion Announces Positive Phase 1 Results for COVID-19 Antibody Therapy
2020-11-12
Spotlight: Celltrion Healthcare’s Remsima Expands to Multiple Medical Uses
2020-07-20
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top